Innovative pharmas gained 9% of sales with severe polarization

Last year, innovative pharmaceutical companies experienced an approximately 9% growth in sales, but reportedly had severe polarization in profitability.

Although general and foreign pharmaceutical companies had a great business performance, but most biopharmaceutical companies had a poor performance, which brought down the average business performance.

Yakup Shinmoon(www.yakup.com) analyzed 2...